Aussie Drug Makers Extend Agreement For Developing Antiviral For Flu
This article was originally published in PharmAsia News
Executive Summary
Australia’s Albany Molecular Research and Biota Holdings say they have agreed to an extension of their agreement to develop and produce the antiviral drug laninamivir for treating influenza.